Today it was announced that Affymetrix would acquire eBioscience for $330 million in cash. The deal is expected to close in Q4 of 2011.
eBioscience, Inc. is a privately-held life science company based out of San Diego, CA with a focus on developing flow cytometry and immunoassay reagents for immunology and oncology research and diagnostics. The purchase by Affymetrix is expected to improve the latter company’s standing from both an operational and fiscal standpoint. Most notably, the Affy team believes this acquisition will greatly boost the company’s portfolio in protein analysis as well as complement their existing genomics franchise.
To read more about the Affymetrix’s acquisition of eBioscience, Inc., please click here.